Get the Stockscreener App
2.38
1.65%
-0.04
After Hours:
2.38
InspireMD Inc. stock is traded at $2.38, with a volume of 46,340.
It is down -1.65% in the last 24 hours and down -5.56% over the past month.
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.
See More
Previous Close:
$2.42
Open:
$2.42
24h Volume:
46,340
Relative Volume:
0.27
Market Cap:
$99.30M
Revenue:
$6.21M
Net Income/Loss:
$-19.92M
P/E Ratio:
-2.2667
EPS:
-1.05
Net Cash Flow:
$-16.76M
1W Performance:
-1.65%
1M Performance:
-5.56%
6M Performance:
-15.30%
1Y Performance:
-11.85%
1-Day Range:
$2.38
$2.45
1-Week Range:
$2.35
$2.46
52-Week Range:
$1.99
$3.798
InspireMD Inc. Stock (NSPR) Company Profile
Name
InspireMD Inc.
Sector
Industry
Phone
972 3 6917691
Address
4 Menorat Hamaor Street, Tel Aviv
Compare NSPR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
2.38 | 100.13M | 6.21M | -19.92M | -16.76M | -1.05 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-07-16 | Initiated | Rodman & Renshaw | Buy |
| Mar-13-15 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-26-13 | Initiated | Oppenheimer | Outperform |
InspireMD Inc. Stock (NSPR) Latest News
InspireMD Inc. stock daily chart insights2025 Trading Recap & Growth Focused Entry Reports - Newser
Published on: 2025-09-12 19:02:19 - Newser
Will InspireMD Inc. stock outperform value stocksJuly 2025 Big Picture & Daily Technical Stock Forecast Reports - baoquankhu1.vn
InspireMD Inc. stock trend outlook and recovery path2025 Buyback Activity & Weekly Stock Breakout Alerts - Newser
What recovery options are there for InspireMD Inc.July 2025 Rallies & Fast Exit and Entry Strategy Plans - Newser
Real time scanner hits for InspireMD Inc. explainedPortfolio Gains Summary & Daily Price Action Insights - Newser
Trend analysis for InspireMD Inc. this weekExit Point & Stepwise Trade Signal Guides - Newser
is inspiremd inc. building a consolidation baseGlobal Markets & Technical Buy Zone Confirmations - Newser
When is the best time to exit InspireMD Inc.Jobs Report & High Win Rate Trade Alerts - Newser
Candlestick signals on InspireMD Inc. stock todayPortfolio Gains Report & Comprehensive Market Scan Reports - Newser
Earnings visualization tools for InspireMD Inc.Insider Selling & Reliable Breakout Stock Forecasts - Newser
Real time social sentiment graph for InspireMD Inc.Market Growth Review & Safe Swing Trade Setups - Newser
Detecting support and resistance levels for InspireMD Inc.2025 Pullback Review & AI Powered Market Trend Analysis - Newser
Parkman Healthcare Partners LLC Boosts Holdings in InspireMD, Inc. $NSPR - MarketBeat
Multi asset correlation models including InspireMD Inc.Quarterly Risk Review & Real-Time Chart Pattern Alerts - Newser
Tick level data insight on InspireMD Inc. volatilityJuly 2025 Catalysts & Smart Investment Allocation Insights - Newser
Applying big data sentiment scoring on InspireMD Inc.Weekly Stock Analysis & AI Optimized Trading Strategy Guides - Newser
What machine learning models say about InspireMD Inc.Quarterly Growth Report & Low Drawdown Trading Strategies - Newser
Full technical analysis of InspireMD Inc. stock2025 AllTime Highs & Real-Time Chart Breakout Alerts - Newser
How hedge fund analytics apply to InspireMD Inc. stock2025 Growth vs Value & Fast Exit and Entry Strategy Plans - Newser
Combining price and volume data for InspireMD Inc.Gap Down & Risk Adjusted Buy and Sell Alerts - Newser
Should you wait for a breakout in InspireMD Inc.Weekly Trend Summary & Real-Time Stock Movement Alerts - Newser
Is InspireMD Inc. reversing from oversold territoryJuly 2025 Market Mood & High Accuracy Trade Signal Alerts - Newser
Visualizing InspireMD Inc. stock with heatmaps2025 Major Catalysts & Verified Momentum Stock Alerts - Newser
Price action breakdown for InspireMD Inc.Quarterly Profit Report & Real-Time Volume Analysis Alerts - Newser
Is InspireMD Inc. stock ready for a breakoutGlobal Markets & Low Risk Growth Stock Ideas - Newser
How to read the order book for InspireMD Inc.2025 Dividend Review & Stepwise Trade Execution Plans - Newser
Can InspireMD Inc. deliver alphaTrade Entry Report & Weekly High Conviction Trade Ideas - Lancaster City Council
Is InspireMD Inc. building a consolidation baseQuarterly Trade Summary & Free Verified High Yield Trade Plans - Newser
InspireMD Inc. stock trend forecastRecession Risk & Trade Opportunity Analysis - Newser
What indicators show strength in InspireMD Inc.July 2025 Trade Ideas & Fast Exit and Entry Strategy Plans - Newser
InspireMD Inc. Stock (NSPR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.14%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):